Skip to main content

DCB Funding Opportunities

Funding Opportunity Announcements (FOA)

Title Announcement Number Opening Date Expiration Date Activity Code
Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards NOT-OD-20-055 03/05/2020 03/06/2023 N/A
Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional) RFA-CA-21-021 09/06/2021 10/07/2021 U01
Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24 Clinical Trial Not Allowed) RFA-CA-21-022 09/06/2021 10/07/2021 U24
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Basic Mechanisms of Health Effects NOT-OD-21-127 06/28/2021 05/08/2023 N/A
Notice of Special Interest (NOSI): Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome Across the Lifespan (R21 Clinical Trial Not Allowed) NOT-OD-21-092 06/28/2021 11/17/2023 R21
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) PAR-21-138 06/07/2021 12/02/2024 N/A
Notice of Intent to Publish a Funding Opportunity Announcement for Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) NOT-CA-21-090 06/24/2021 N/A N/A
Notice of Intent to Publish a Funding Opportunity Announcement for Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) NOT-CA-21-091 06/24/2021 N/A N/A
Notice of Intent to Publish a Funding Opportunity Announcement for Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed) NOT-CA-21-060 04/21/2021 N/A N/A
Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions (TBEL) (U24 Clinical Trial Not Allowed) NOT-CA-21-061 04/21/2021 N/A N/A
Notice of Special Interest (NOSI): Biology of Lung and Head and Neck Preneoplasia NOT-CA-21-057 05/06/2021 05/08/2023 N/A
Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed) RFA-CA-21-041 10/01/2021 11/02/2021 U01
Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (PSRC CDMC) (U24 Clinical Trial Not Allowed) RFA-CA-21-042 10/01/2021 11/02/2021 U24
Notice of Intent to Publish a Funding Opportunity Announcement for Acquired Resistance to Therapy Network (ARTNet) (U54 Clinical Trial Not Allowed) NOT-CA-21-063 04/28/2021 N/A N/A
Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet) (U24 Clinical Trial Not Allowed) NOT-CA-21-064 04/28/2021 N/A N/A
Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional) RFA-CA-21-026 09/08/2021 10/09/2021 R01
Coordinating Center for the Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed) RFA-CA-21-027 09/08/2021 10/09/2021 U24
SBIR Program Solicitation: Therapeutics - Development of Senotherapeutic Agents for Cancer Treatment  PHS 2022-1 TBD TBD N/A
Reminder: NIH Natural Disaster Policy – Wildfires NOT-OD-20-176 09/25/2020 N/A N/A
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) PA-21-071 11/16/2020 05/08/2023 N/A
Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers NOT-CA-20-022 05/7/2020 01/08/2023 N/A
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed) PAR-20-088 03/01/2020 04/02/2022 R01
Co-infection and Cancer (R21 Clinical Trial Not Allowed) PAR-20-061 02/17/2020 01/08/2023 R21
Co-infection and Cancer (R01 Clinical Trial Not Allowed)  PAR-20-062 02/06/2020 01/08/2023 R01
Small Cell Lung Cancer (SCLC) Consortium: Biology, Therapy and Resistance (U01 Clinical Trial Not Allowed) PAR-19-361 10/12/2019 03/12/2022 U01
Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) PAR-19-353 09/21/2019 05/28/2022 R01
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) PAR-19-354 09/21/2019 05/28/2022 R21
Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional) PAR-19-287 05/22/2019 11/16/2021 U01
Microbial-based Cancer Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) PAR-19-193 05/05/2019 05/08/2022 R01
Microbial-based Cancer Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) PAR-19-194 05/16/2019 05/08/2022 R21
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) PAR-19-199 05/10/2019 11/09/2021 R21
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) PAR-19-198 05/10/2019 11/09/2021 R01
Biology of Bladder Cancer (R01 Clinical Trial Optional) PAR-19-183 05/05/2019 05/08/2022 R01
Biology of Bladder Cancer (R21 Clinical Trial Optional) PAR-19-184 05/16/2019 05/08/2022 R21
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) PAR-19-113 01/05/2019 01/08/2022 R01
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed) PA-18-876 09/05/2018 09/08/2021 R01
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) PA-18-902 09/05/2018 09/08/2021 R01
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) PAR-20-131 05/05/2020 05/08/2023 R01